Citation

Farinde A. J. Pharm. Pract. 2011; 24(6): 568-570.

Copyright

(Copyright © 2011, SAGE Publishing)

DOI

10.1177/0897190011416672

PMID

21987528

Abstract

The use of topiramate therapy to control the neuropsychiatric and behavioral disturbances in individuals with mental and/or developmental disabilities with co-occurring psychiatric disturbances has become a standard of practice in many long-term care assisted living facilities. With increased utilization of this anticonvulsant, there has been a rise in the number documented cases of agitation and/or aggressive behavior associated with topiramate therapy. It is the purpose of this article to explore the current literature documenting the connection between topiramate utilization and the development of aggressive and/or agitated behavior.

Language: en